5,800.00

Content Details
Information on this page was last modified on : 2021/05/11 9:21:22 PM

Strattera capsule 40 mg 28's

Belongs to Category,

Strattera capsule contains Atomoxetine | belongs to Selective noradrenaline reuptake inhibitor

Alternate brands of Strattera capsule 40 mg 28’s

Brand Name Price Savings
Strattera capsule 60 mg 28’s  6,100.00 You will pay -300 more
Strattera capsule 25 mg 28’s  5,800.00 You can save 0
Strattera capsule 18 mg 28’s  5,500.00 You can save 300
Strattera capsule 10 mg 28’s  5,500.00 You can save 300
Attentra tablet 40 mg 30’s  1,250.00 You can save 4550
List of alternate brands

How it works

Strattera capsule 40 mg 28’s work by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Side effects

Major & minor side effects for Strattera capsule 40 mg 28’s

  • Itching
  • Skin Rash
  • Dizziness
  • Cough
  • Headache
  • Fever
  • Nausea and Vomiting
  • Shortness of breath
  • Abnormal dreams
  • Back pain

Uses of Strattera capsule 40 mg 28’s

What is it prescribed for?

  • ADHD

    This medicine is used to treat attention-deficit hyperactivity disorder, a condition characterized by symptoms such as difficulty in paying attention, hyperactivity, impulsiveness (talking excessively, interrupting others), etc.

Concerns

Frequently asked questions

  • Onset of action

    The effect of this medicine is cumulative and it may take up to 4 weeks of therapy before a marked effect is observed.

  • Duration of Effect

    The amount of time for which this medicine remains active in the body is not clinically established.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit-forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to Strattera capsule 40 mg 28’s or any other inactive ingredients present along with it.

  • Narrow angle glaucoma

    This medicine is not recommended for use in patients suffering from narrow-angle glaucoma due to the increased risk of worsening of the patient's condition.

  • Monoamine oxidase inhibitors (MAOI)

    This medicine is not recommended for use in patients receiving therapy with monoamine oxidase inhibitors or within 2 weeks of discontinuing therapy with a monoamine oxidase inhibitor due to the increased risk of serious adverse effects.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

General Warnings
  • Driving or Operating Machinery

    This medicine may cause symptoms such as blurred vision, dizziness, drowsiness, tiredness, weakness, etc. in some patients. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

  • Urinary Retention

    This medicine should be used with extreme caution in patients suffering from urinary disorders due to the increased risk of severe adverse effects such as urinary retention and urinary hesitancy. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

  • Liver Diseases

    This medicine should be used with extreme caution in patients suffering from liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

  • Suicidal Tendency

    This medicine may increase the risk of suicidal thoughts in some patients. This risk is especially higher in patients suffering from depression and other psychiatric disorders. Patients should be monitored closely for any change in mood or behavior during treatment with this medicine. Appropriate caregiver/patient counseling, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

  • Use in children

    This medicine is not recommended for use in patients less than 6 years of age since the safety and efficacy of use are not clinically established.

Dosage

  • Missed Dose

    The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

  • Overdose

    Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Interaction with Medicines
  • Imatinib Mesylate moderate
  • Ivabradine severe
  • Ofloxacin moderate
  • Azithromycin moderate
  • Citalopram severe
  • Haloperidol severe
  • Clozapine severe
  • Dopamine moderate
Disease interactions
  • severe

    This medicine should be used with extreme caution in patients with a history of liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

  • moderate

    This medicine should be used with caution in patients with a history of kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

  • severe

    This medicine should be used with extreme caution in patients suffering from seizures disorder due to the increased risk of worsening of the patient's condition. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

  • moderate

    This medicine should be used with extreme caution in patients suffering from psychiatric disorders due to the increased risk of worsening of the patient's condition. Patients should be monitored closely for any change in mood and behavior during treatment with this medicine. Appropriate caregiver/patient counseling, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

  • severe

    This medicine should be used with extreme caution in patients suffering from cardiovascular diseases due to the increased risk of worsening of the patient's condition. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

References

Additional Information:

what are the adverse effects of Strattera capsule 40 mg 28’s?

Abdominal pain, decreased appetite, weight loss, anorexia, early waking, somnolence, dizziness, irritability, mood swings, mydriasis, GI upset, skin reactions, Discontinue if signs of liver injury.

What happens if I miss a dose of Strattera capsule 40 mg 28’s?

Attention deficit hyperactivity disorder: Adults: gt;70 kg: Initial: 40 mg/day given every morning or evenly divided doses in morning & late afternoon/early evening Titrate: Increase after minimum of 3 day to target dose of about 80 mg/day. After 2-4 wk, may increase to max of 100 mg/day. Max: 100 mg/day.
Children: Doses above 100 mg daily is not recommended for use. Total daily dose may be given either as a single dose in the morning or in 2 divided doses with last dose no later than early evening.
Attention deficit hyperactivity disorder: Over 6 yr (body-weight under 70 kg), initially 500 mcg/kg daily for 7 days, increased according to response; usual maintenance dose 1.2 mg/kg daily, but may be increased to 1.8 mg/kg daily, max 120 mg daily; Over 6 yr (body-weight over 70 kg), initially 40 mg daily for 7 days, increased according to response; usual maintenance dose 80 mg daily, but may be increased to max 120 mg daily; under the direction of a specialist.

One of the following licensed pharmacy from the nearest location will deliver Strattera capsule 40 mg 28’s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Reviews

There are no reviews yet.

Be the first to review “Strattera capsule 40 mg 28’s”
Shopping Cart